Literature DB >> 31229318

Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease.

Audrey Dionne1, Emily M Bucholz1, Kimberlee Gauvreau1, Patrick Gould2, Mary Beth F Son3, Annette L Baker2, Sarah D de Ferranti1, David R Fulton1, Kevin G Friedman1, Jane W Newburger4.   

Abstract

OBJECTIVE: To evaluate the association of neighborhood socioeconomic status (SES) with time to intravenous immunoglobulin treatment, length of stay (LOS), and coronary artery aneurysms (CAAs) in patients with Kawasaki disease. STUDY
DESIGN: We examined the relationship of SES in 915 patients treated at a large academic center between 2000 and 2017. Neighborhood SES was measured using a US census-based score derived from 6 measures related to income, education, and occupation. Linear and logistic regression were used to examine the association of SES with number of days of fever at time of treatment, LOS, and CAA.
RESULTS: Patients in the lowest SES quartile were treated later than patients with greater SES (7 [IQR 5, 9] vs 6 [IQR 5, 8] days, P = .01). Patients in the lowest SES quartile were more likely to be treated after 10 days of illness, with an OR 1.9 (95% CI 1.3-2.8). In multivariable analysis, SES remained an independent predictor of the number of days of fever at time of treatment (P = .01). Patients in the lowest SES quartile had longer LOS than patients with greater SES (3 [IQR 2, 5] vs 3 [IQR 2, 4], P = .007). In subgroup analysis of white children, those in the lowest SES quartile vs quartiles 2-4 were more likely to develop large/giant CAA 17 (12%) vs 30 (6%), P = .03.
CONCLUSIONS: Lower SES is associated with delayed treatment, prolonged LOS, and increased risk of large/giant CAA. Novel approaches to diagnosis and education are needed for children living in low-SES neighborhoods.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary artery aneurysm; delayed diagnosis; delayed treatment; hospital length of stay

Year:  2019        PMID: 31229318     DOI: 10.1016/j.jpeds.2019.05.024

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.

Authors:  Jennifer J Y Lee; Brian M Feldman; Brian W McCrindle; Ping Li; Rae Sm Yeung; Jessica Widdifield
Journal:  Pediatr Res       Date:  2022-08-24       Impact factor: 3.953

2.  Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.

Authors:  Yaheng Lu; Tingting Chen; Yizhou Wen; Feifei Si; Xindan Wu; Yanfeng Yang
Journal:  BMC Pediatr       Date:  2021-09-16       Impact factor: 2.125

3.  Kawasaki Disease and Clinical Outcome Disparities Among Black Children.

Authors:  Luz A Padilla; Jacqueline L Collins; Adeniyi J Idigo; Yung Lau; Michael A Portman; Sadeep Shrestha
Journal:  J Pediatr       Date:  2020-09-24       Impact factor: 4.406

4.  Association of Clinical Severity With Family Affluence-Based Socioeconomic Status Among Hospitalized Pediatric Hand, Foot, and Mouth Disease Patients in Henan, China: A Single Hospital-Based Case Series Study.

Authors:  Kai Wang; Fang Wang; Yu Li; Lu Liang; Peng Cui; Shujuan Han; Yonghong Zhou; Qi Qiu; Yibing Cheng; Chun Guo; Mengyao Zeng; Lu Long; Tianchen Zhang; Hongjie Yu
Journal:  Open Forum Infect Dis       Date:  2021-03-26       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.